Please assess the completion status of the following clinical trial:

Trial Title: Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Admission to the UMC Utrecht.~2. Age 18 years or over.~3. Aneurysmal SAH, demonstrated on CT-angiography or cerebral angiography, with onset less than 72 hours before admission.~4. A level of consciousness corresponding to a Glasgow Coma Sum Score above 8, as in patients with lower Glasgow Coma Sum Scores, assessment of further deterioration may be less reliable.~Exclusion Criteria:~1. Symptomatic aneurysm not yet treated by coiling or clipping. Co-existing asymptomatic cerebral aneurysms are no reason for exclusion, since previous studies found no increased risk of rupture of such aneurysms during hypertensive and hypervolemic treatment.(26)~2. Co-existing severe head injury.~3. A history of a cardiac rhythm disorder, necessitating medical treatment.~4. A history of a left ventricular pump failure, necessitating medical treatment.~5. Pregnancy.~6. Known allergy for CT-contrast agents.~7. Renal failure, defined as a serum creatinine \> 150 µmol/l, because of the risk of contrast nephropathy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: NO_INTERVENTION): No induced hypertension (reference group)
- 2 (Type: EXPERIMENTAL): Induced hypertension with a MAP of 30 mmHg above the average MAP on the previous day; during 24-36 hours, until a perfusion CT scan has been performed

Based on this trial design, predict the completion outcome and termination type (if applicable).